Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 6
1966 3
1968 2
1970 2
1971 5
1972 1
1973 1
1975 2
1976 6
1977 2
1978 1
1979 3
1980 1
1981 1
1982 1
1983 4
1986 5
1987 1
1988 2
1990 2
1993 2
1994 1
1995 1
1997 2
2001 1
2003 1
2004 2
2005 1
2006 1
2008 1
2010 1
2012 1
2014 1
2017 1
2018 1
2020 2
2022 2
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

72 results
Results by year
Filters applied: . Clear all
Page 1
A Randomized, Double-Blind, Placebo-Controlled Trial of Naproxen With or Without Orphenadrine or Methocarbamol for Acute Low Back Pain.
Friedman BW, Cisewski D, Irizarry E, Davitt M, Solorzano C, Nassery A, Pearlman S, White D, Gallagher EJ. Friedman BW, et al. Ann Emerg Med. 2018 Mar;71(3):348-356.e5. doi: 10.1016/j.annemergmed.2017.09.031. Epub 2017 Oct 28. Ann Emerg Med. 2018. PMID: 29089169 Free PMC article. Clinical Trial.
Additionally, patients were randomized to receive a 1-week supply of orphenadrine 100 mg, to be used twice a day as needed, methocarbamol 750 mg, to be used as 1 or 2 tablets 3 times per day as needed, or placebo. ...Adverse events were reported by 17% (95% CI 10% to 28%) …
Additionally, patients were randomized to receive a 1-week supply of orphenadrine 100 mg, to be used twice a day as needed, methocarb …
A controlled clinical trial of chlormezanone, orphenadrine, orphenadrine/paracetamol and placebo in the treatment of painful skeletal muscle spasms.
Valtonen EJ. Valtonen EJ. Ann Clin Res. 1975 Apr;7(2):85-8. Ann Clin Res. 1975. PMID: 1103709 Clinical Trial.
Four hundred patients with painful muscle spasm caused by five common musculoskeletal diseases were included in a double-blind controlled trial of chlormezanone, orphenadrine, orphenadrine/paracetomol and placebo. Patients were treated for one week and then asked fo …
Four hundred patients with painful muscle spasm caused by five common musculoskeletal diseases were included in a double-blind controlled tr …
Norgesic.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 1965 Mar 26;7(7):27-8. Med Lett Drugs Ther. 1965. PMID: 5318148 Clinical Trial. No abstract available.
Controlled clinical trial of oral and parenteral nefopam hydrochloride. A novel and potent analgesic drug.
Gassel MM, Diamantopoulos E, Petropoulos V, Hughes AC, Ballesteros ML, Ré ON. Gassel MM, et al. J Clin Pharmacol. 1976 Jan;16(1):34-41. doi: 10.1002/j.1552-4604.1976.tb01489.x. J Clin Pharmacol. 1976. PMID: 1107359 Clinical Trial.
The results of a controlled, double-blind clinical trial are reported demonstrating the potency of analgesia produced by orally and parenterally administered nefopam HCl in hospitalized patients with pain principally of skeletal and neuromuscular origin. The drug is an analogue o …
The results of a controlled, double-blind clinical trial are reported demonstrating the potency of analgesia produced by orally and parenter …
Comparison of the analgesic effects of a fixed-dose combination of orphenadrine and diclofenac (Neodolpasse) with its single active ingredients diclofenac and orphenadrine: a placebo-controlled study using laser-induced somatosensory-evoked potentials from capsaicin-induced hyperalgesic human skin.
Schaffler K, Reitmeir P, Gschanes A, Eggenreich U. Schaffler K, et al. Drugs R D. 2005;6(4):189-99. doi: 10.2165/00126839-200506040-00001. Drugs R D. 2005. PMID: 15991879 Clinical Trial.
Twenty-four healthy female and male subjects received single infusions of Neodolpasse, orphenadrine, diclofenac or saline solution over 60 minutes. Infusions were separated by a 1-week washout period. ...RESULTS: Although none of the active treatments had a significant eff …
Twenty-four healthy female and male subjects received single infusions of Neodolpasse, orphenadrine, diclofenac or saline solution ov …
[Analgesic and opioid-sparing effects of a fixed combination of diclofenac and orphenadrine in the early postoperative period in cardiac surgery patients].
Eremenko AA, Sorokina LS, Ryabova DV, Urbanov AV. Eremenko AA, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(10):109-115. doi: 10.17116/jnevro2022122101109. Zh Nevrol Psikhiatr Im S S Korsakova. 2022. PMID: 36279236 Clinical Trial. Russian.
In 20 patients (group 1), "Neodolpasse" (a fixed combination of 30 mg Orphenadrine and 75 mg Diclofenac) was administered immediately after trachea extubation. ...CONCLUSION: There were demonstrated high analgesic efficacy, safety and significant opioid-sparing effect of a …
In 20 patients (group 1), "Neodolpasse" (a fixed combination of 30 mg Orphenadrine and 75 mg Diclofenac) was administered immediately …
Orphenadrine in treatment of muscle cramps in cirrhotic patients: a randomized study.
Abd-Elsalam S, Ebrahim S, Soliman S, Alkhalawany W, Elfert A, Hawash N, Elkadeem M, Badawi R. Abd-Elsalam S, et al. Eur J Gastroenterol Hepatol. 2020 Aug;32(8):1042-1045. doi: 10.1097/MEG.0000000000001622. Eur J Gastroenterol Hepatol. 2020. PMID: 31834056 Clinical Trial.
They were divided into two arms: 62 patients administrated orphenadrine and 62 administrated placebo. They were followed up till 2 weeks after the end of therapy. Muscle cramps were evaluated using questionnaire as regards severity, duration, and frequency. Also, side effe …
They were divided into two arms: 62 patients administrated orphenadrine and 62 administrated placebo. They were followed up till 2 we …
Ondansetron and dexamethasone versus standard combination antiemetic therapy. A randomized trial for the prevention of acute and delayed emesis induced by cyclophosphamide-doxorubicin chemotherapy and maintenance of antiemetic effect at subsequent courses.
Campora E, Giudici S, Merlini L, Rubagotti A, Rosso R. Campora E, et al. Am J Clin Oncol. 1994 Dec;17(6):522-6. Am J Clin Oncol. 1994. PMID: 7977174 Clinical Trial.
The antiemetic efficacy of ondansetron and dexamethasone (Ondex) was randomly compared to that of high-dose metoclopramide, dexamethasone, and orphenadrine (Control) in the prevention of emesis induced by cyclophosphamide-doxorubicin chemotherapy in 64 chemotherapy-naive b …
The antiemetic efficacy of ondansetron and dexamethasone (Ondex) was randomly compared to that of high-dose metoclopramide, dexamethasone, a …
A comparative trial of orphenadrine and tofenacin in the control of depression and extrapyramidal side-effects associated with fluphenazine decanoate therapy.
Capstick N, Pudney H. Capstick N, et al. J Int Med Res. 1976;4(6):435-40. doi: 10.1177/030006057600400610. J Int Med Res. 1976. PMID: 800383 Clinical Trial.
A trial involving patients receiving fluphenazine decanoate was designed to compare the effects of orphenadrine hydrochloride (Disipal) and its major metabolite, tofenacin hydrochloride (Elamol) on the Parkinsonian side-effects and depression occurring during fluphenazine …
A trial involving patients receiving fluphenazine decanoate was designed to compare the effects of orphenadrine hydrochloride (Disipa …
72 results